期刊
DIABETES & METABOLISM
卷 32, 期 3, 页码 205-213出版社
MASSON EDITEUR
DOI: 10.1016/S1262-3636(07)70270-7
关键词
proteine kinase C; ruboxistaurin; microvascular complications; diabetes
PKC comprises a superfamily of isoenzymes that is activated in, response to various stimuli. Hyperglycaemia induces the activation of different PKC isoforms. However, the PKC-beta isoform appears to be preferentially activated by high glucose levels and has been shown to be associated with diabetic vascular complications. In vitro and in vivo animal studies have shown that ruboxistaurin mesylate, a novel selective inhibitor of PKC-beta ameliorates the biochemical and functional consequences of PKC activation and may have the potential to reduce the burden of vascular complications associated with diabetes. Results of the first phase-II and phase-III trials evaluating the efficacy of this compound on diabetic microvascular complications have been published recently. They confirm that this compound may favorably influence the evolution of diabetic microvascular complications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据